Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, PhD, a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/25/17 | $45,000,000 | Series B |
Arix Bioscience MPM Capital New Leaf Venture Partners Taiho Ventures | undisclosed |
